American International Group’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-19,636
Closed -$28.7K 3126
2023
Q1
$28.7K Buy
19,636
+391
+2% +$750 ﹤0.01% 2845
2022
Q4
$31.2K Sell
19,245
-70
-0.4% -$161 ﹤0.01% 2859
2022
Q3
$65K Buy
19,315
+273
+1% +$1.23K ﹤0.01% 2735
2022
Q2
$69K Sell
19,042
-231
-1% -$1.05K ﹤0.01% 2761
2022
Q1
$139K Sell
19,273
-1,356
-7% -$11.6K ﹤0.01% 2451
2021
Q4
$280K Sell
20,629
-618
-3% -$9.67K ﹤0.01% 2163
2021
Q3
$445K Sell
21,247
-504
-2% -$10.8K ﹤0.01% 1932
2021
Q2
$521 Buy
21,751
+13,077
+151% +$331K ﹤0.01% 1894
2021
Q1
$254 Buy
8,674
+180
+2% +$5.27K ﹤0.01% 2236
2020
Q4
$254 Buy
+8,494
New +$266K ﹤0.01% 2152

Other funds holding KRON

American International Group's KRON Position: Q2 2023 in Review

American International Group sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 19,636 shares — an estimated $28.7K sold.

American International Group first reported a position in KRON in Q4 2020 and held it in 10 quarters. The position peaked at $445K in Q3 2021. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • American International Group reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 19,636 Kronos Bio shares in Q2 2023, an estimated $28.7K.
  • American International Group first reported a position in Kronos Bio in Q4 2020 and held it in 10 quarters.
  • American International Group's Kronos Bio position peaked at $445K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.